Potent inhibitory effects of the 5'-triphosphates of (E)-5-(2-bromovinyl)-2'-deoxyuridine and (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on DNA polymerase gamma.
(E)-5-(2-Bromovinyl)-2'-deoxyuridine 5'-triphosphate (BrVdUTP) and (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil 5'-triphosphate (BrVarafUTP), which are known as specific inhibitors of herpes simplex viral (type 1 and 2) DNA polymerase, were found to be strong inhibitors of DNA polymerase gamma from human KB and murine myeloma cells. In fact BrVdUTP and BrVarafUTP were found to be stronger inhibitors of DNA polymerase gamma than of other DNA polymerases having viral (herpes simplex virus or retrovirus) origin or cellular (eukaryotic alpha and beta, or prokaryotic) origin. The mode of inhibition of DNA polymerase gamma by BrVdUTP and BrVarafUTP was competitive with respect to dTTP, the normal substrate. Whereas BrVdUTP was an efficient substrate for DNA polymerase gamma and other DNA polymerases that were examined, BrVarafUTP failed to serve as a substrate for DNA synthesis. Ki values for BrVdUTP (40 nM) and BrVarafUTP (7 nM) with DNA polymerase gamma, as determined with (rA)n.(dT) as the template.primer, were much smaller than the Km values for dTTP (0.16 microM and 0.71 microM for murine and human DNA polymerase gamma, respectively). Thus, the affinity of BrVdUTP or BrVarafUTP for DNA polymerase gamma was much stronger than that of dTTP.
Ono
K
K
Laboratory of Viral Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Nakane
H
H
De Clercq
E
E
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001088:Arabinonucleotides / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002460:Cell Line; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D004258:DNA Polymerase III / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D004261:DNA Replication / Q000187:drug effects*; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007624:KB Cells; D007700:Kinetics; D019384:Nucleic Acid Synthesis Inhibitors; D018139:Simplexvirus / Q000201:enzymology
D000998:Antiviral Agents; D001088:Arabinonucleotides; D019384:Nucleic Acid Synthesis Inhibitors; C020235:brivudine; C065019:5-(2-bromovinyl)-1-arabinofuranosyluracil 5'-triphosphate; D004256:DNA Polymerase I; D004257:DNA Polymerase II; D004258:DNA Polymerase III; D001973:Bromodeoxyuridine